COMMUNIQUÉS West-GlobeNewswire

Diversicare Wins Customer and Employee Approved Awards From NRC Health
15/05/2019
BRENTWOOD, Tenn., May 15, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) has earned a 2019 Customer Approved Award and a 2019 Employee Approved Award from Lincoln, Nebraska–based [...]
Philips issues inaugural Green Innovation Bond
15/05/2019
May 15, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its issuance of EUR 750 million 0. [...]
Nextech to Showcase Innovative Solutions for Plastic Surgeons at The Aesthetic Meeting 2019
15/05/2019
Streamlined functionalities, including e-Prescribing and patient portal, offer improved care options for plastic surgeons TAMPA, Fla., May 15, 2019 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of healthcare [...]
BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th Annual PACT Enterprise Awards
15/05/2019
MALVERN, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- BioTelemetry (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, [...]
Announcements in Conjunction With Theratechnologies Annual Meeting
15/05/2019
MONTREAL, May 15, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders. As part of the meeting, shareholders proceeded to elect the Company’s Board of Directors for a [...]
Annonces en marge de l’assemblée annuelle de Theratechnologies
15/05/2019
MONTRÉAL, 15 mai 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (TSX : TH) a tenu aujourd’hui son assemblée annuelle des actionnaires. Au cours de l’assemblée, les actionnaires ont élu les membres du conseil d’ [...]
Q1 2019 Financial Information and Corporate Business Update
15/05/2019
Q1 2019 Financial Information and Corporate Business Update 1 Cash and cash equivalents of €47.3m as at 31 March 2019, in line with expectations Revenues increase to €1.0m in Q1 2019 compared to Q1 2018 Significant [...]
Information financière et point sur l’activité du 1er trimestre 2019
15/05/2019
Information financière et point sur l’activité du 1 er trimestre 2019 1 Trésorerie et équivalents de trésorerie à 47,3 M€ au 31 mars 2019 conformément aux prévisions Chiffre d’affaires du trimestre de 1,0 M€ en [...]
Precipio Regains Nasdaq Listing Compliance
15/05/2019
NEW HAVEN, Conn., May 15, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that on May 15, 2019 the Company received a letter from Nasdaq informing the Company that it [...]
Corrected - Olainfarm Group sales in April increase by 14%
15/05/2019
This is corrected release of previous announcement. Correction relate to comparison to 2018 figures in consolidated sales in April. Consolidated sales – April and 4 months Preliminary consolidated results of JSC [...]
Sienna Announces May Dividend
15/05/2019
MARKHAM, Ontario, May 15, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “ Common Share ”) [...]
Mateon Reports First Quarter 2019 Financial Results
15/05/2019
SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, [...]
Lixte Biotechnology's LB-100 to be Evaluated by the National Cancer Institute in a Clinical Study of LB-100's Ability to Enter Recurrent Glioblastoma Multiforme Brain Tumors
15/05/2019
EAST SETAUKET, NY, May 15, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) announced the opening of a pharmacologic study of the ability of its lead clinical compound, LB-100, to enter the [...]
Olainfarm Group sales in April increase by 45%
15/05/2019
Consolidated sales – April and 4 months Preliminary consolidated results of JSC Olainfarm for April 2019, show that the Group has made sales worth 12.6 million euros, which represents an increase by 45% compared to [...]
INmune Bio Reports First Quarter 2019 Financial Results and Provides Shareholder Update
15/05/2019
LA JOLLA, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Generex Biotechnology Announces Postponement of Its May 15th Investor Conference Call
15/05/2019
MIRAMAR, Fla., May 15, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that the company has postponed the [...]
Evolus Announces First Shipment of Jeuveau™ (prabotulinumtoxinA-xvfs) to Customers in the United States
15/05/2019
Jeuveau™ Experience Treatment (J.E.T.) Planned to Rollout to Approximately 3,000 Practices Nation-wide NEWPORT BEACH, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company [...]
Auris Medical Announces Closing of Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD
15/05/2019
Hamilton, Bermuda, May 15, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]
Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0022, a Novel MET/CSF1R/SRC Inhibitor
15/05/2019
SAN DIEGO, May 15, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs that address treatment resistance, today announced clearance by the U.S. [...]

Pages